GF Fund Management logo

GF Fund Management

Asia, Guangdong, China, Zhuhai

Description

GF Fund Management is an investment firm.

Investor Profile

GF Fund Management has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Bitcoin, Blockchain, Finance.

Stage Focus

  • Series A (50%)
  • Post Ipo Equity (50%)

Country Focus

  • United States (50%)
  • China (50%)

Industry Focus

  • Bitcoin
  • Blockchain
  • Finance
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GF Fund Management frequently co-invest with?

Nirvana Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
ZhenFund
Asia, Beijing, China, Beijing
Co-Investments: 1
Node Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Coin Capital
North America, Colorado, United States, Denver
Co-Investments: 1
FBG Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
MV
North America, New York, United States, New York
Co-Investments: 1
INBlockchain
Asia, Beijing, China, Beijing
Co-Investments: 1
Viking Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
DHVC
North America, California, United States, Palo Alto
Co-Investments: 1
SC
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by GF Fund Management?

Dizal Pharma

Shanghai, Shanghai, China

Dizal Pharma is a research-based biotechnology company.

BiotechnologyPharmaceutical
Post Ipo EquityApr 17, 2025
Amount Raised: $246,169,029
Hydro Protocol

Seattle, Washington, United States

Hydro Protocol is a DeFi developer to create dynamic marketplaces for decentralized assets.

BitcoinBlockchainFinance
Series AJan 9, 2018